IGC Pharma, Inc. (IGC) vs Seres Therapeutics, Inc. (MCRB)
- IGC Pharma, Inc. IGC 0.25 0.00%
- Seres Therapeutics, Inc. MCRB 2.46 −2.77%
IGC Pharma, Inc. and Seres Therapeutics, Inc. are both Biotechnology companies. IGC Pharma, Inc. and Seres Therapeutics, Inc. are of similar size ($26.3M and $25.2M). IGC Pharma, Inc. grew revenue faster over the last twelve months: −13.4% against −98.5%. IGC Pharma, Inc. has the higher net margin (−795.5% vs −1,192.9%) and the higher return on invested capital (−91.5% vs −277.3%). Across the 18 metrics below, IGC Pharma, Inc. leads on 11 and Seres Therapeutics, Inc. on 7.
Valuation
Profitability
| Metric | IGC | MCRB | Biotechnology median |
|---|---|---|---|
| Gross margin | 32.33% | 100.00% | 65.16% |
| Operating margin | (912.44%) | (4,462.77%) | 0.00% |
| Net margin | (795.46%) | (1,192.94%) | 0.00% |
| Free cash flow margin | (516.53%) | (2,721.83%) | 0.00% |
| Return on equity | (143.46%) | (66.57%) | (56.36%) |
| Return on assets | (100.44%) | (18.31%) | (48.04%) |
| Return on invested capital | (91.53%) | (277.30%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack